View today's stock price, news and analysis for Nektar Therapeutics (NKTR). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more. Feb 24, 2021 4:00 p.m. ET EST Loading mo

NKTR-118 är en oral opioidantagonist i klinisk utveckling för behandling MUSD. Två av våra aktiefonder för medarbetare, AstraZeneca Share.

Investors in Nektar Therapeutics had a tough year, with a total loss of 22%, against a market gain of about 27%. Even the share prices of good stocks drop sometimes, but we want to see improvements in the fundamental metrics of a business, before getting too interested. How has Nektar Therapeutics's share price performed over time and what events caused price changes? Latest Share Price and Events Stable Share Price : NKTR is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 8% a week. 2021-04-03 · The share price of Nektar Therapeutics (NASDAQ:NKTR) raised 2.00% to close Thursday’s market session at $20.40, higher as compared to yesterday’s close. The stock price fluctuated between $19.78 and $20.89 throughout the trading session with the volume trading being 791296 shares, which represented a significant variation when compared to the three months average volume of 1.32 million shares.

Nektar therapeutics stock price

Volatility Over Time: Enjoy free access to the POWR Ratings for all stocks and ETFs on the quote pages. Just enter your email address below. NKTR Stock Summary. A stock valuation and forecasting report include rating, fair value assessment, return forecasts, market ratio-based valuations and comparable analysis. Available and financials.

11,4 %. Fondens active share. 2018-06-30.

Nektar Therapeutics initiated at hold with $18 price target at Stifel MarketWatch. Wednesday, April 22, 2020. 07:24 AM ET. Nektar Therapeutics started at buy with $26 stock price target at Benchmark MarketWatch. Tuesday, January 14, 2020.

How has Nektar Therapeutics's share price performed over time and what events caused price changes? Latest Share Price and Events Stable Share Price : NKTR is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 8% a week. 2021-04-03 · The share price of Nektar Therapeutics (NASDAQ:NKTR) raised 2.00% to close Thursday’s market session at $20.40, higher as compared to yesterday’s close. The stock price fluctuated between $19.78 and $20.89 throughout the trading session with the volume trading being 791296 shares, which represented a significant variation when compared to the three months average volume of 1.32 million shares.

New York Stock Exchange Inc.. T ROWE PRICE GROUP INC. NEKTAR THERAPEUTICS. .

8,87 % T Rowe Price Group Inc. US. 2 596. 0,09%. 0,09% Nektar Therapeutics. US. 917. 0,03%.

Fondens active share.
Beck serien ordning

Get Our PREMIUM Forecast Now, from ONLY $7.49! - Try Now Risk-Free - Money-back guarantee!

Their average twelve-month price target is $25.29, suggesting a possible upside of 30.4%.
Zloty sek historik

This year the report Cancer in Norway presents cancer rates by immigrant group “Oslo Cancer Cluster provides a unique opportunity to share Nektar Therapeutics is not just any company when it comes to immunotherapy.

ET EST Loading mo Real time Nektar Therapeutics (NKTR) stock price quote, stock graph, news & analysis. Returns as of 2/24/2021 Returns as of 2/24/2021 Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financi Ever wondered how to buy stock in Nektar Therapeutics? We explain how and compare the best share dealing platforms. Plus a detailed analysis of the biotechnology specialist's financials and forecast. Finder is committed to editorial indepen : Get the latest Cerenis Therapeutics stock price and detailed information including news, historical charts and realtime prices.

2021-04-20 · Nektar Therapeutics. Stock. , NKTR. 18.18 -0.63 -3.35%. Official Close 4/20/2021 NAS. Add to watchlist. Start Trading >>. Plus500. 76.4% of retail CFD accounts lose money.

2021-04-23 The average analyst price target of $28.60 implies more than 27% upside potential to current levels. Shares have jumped 32% so far this year. Nektar scores a 9 out of 10 from TipRanks’ Smart Nektar Therapeutics stock price target cut to $19 from $38 at SVB Leerink. Aug. 20, 2019 at 7:43 a.m.

$20.27. NKTR.